
Moderna Pays $950M to Settle mRNA Vaccine Patent Dispute
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
%2Ffile%2Fattachments%2F2988%2F13749909_712067.jpg)












